Click to Share
 

Ophthalmic Press Releases

Exclusive News
Topics Locations Industries Dates

By IVIEW Therapeutics Inc.
IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share